Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Huntington Disease (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Huntington Disease (diet therapy) < Huntington Disease (drug therapy) < Huntington Disease (enzymology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
000018 (1999) H D Rosas [États-Unis] ; W J Koroshetz ; B G Jenkins ; Y I Chen ; D L Hayden ; M F Beal ; M E CudkowiczRiluzole therapy in Huntington's disease (HD).
000172 (1999) K R Müller-Vahl [Allemagne] ; U. Schneider ; H M EmrichNabilone increases choreatic movements in Huntington's disease.
000212 (2000) H H Fernandez [États-Unis] ; J H Friedman ; J. Grace ; S. Beason-HazenDonepezil for Huntington's disease.
000C63 (2003) Daphna Joel [Israël] ; Liat Ayalon ; Ricardo Tarrasch ; Ina WeinerDeficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
000D40 (2004) Jürgen Andrich [Allemagne] ; Carsten Saft ; Anneliese Arz ; Birgit Schneider ; Markus W. Agelink ; Peter H. Kraus ; Wilfried Kuhn ; Thomas MüllerHyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.
000E47 (2004) Madhavi Thomas [États-Unis] ; Tetsuo Ashizawa ; Joseph Jankovic [États-Unis]Minocycline in Huntington's disease: a pilot study.
001042 (2004) Marina De Tommaso [Italie] ; Nicola Specchio ; Vittorio Sciruicchio ; Olimpia Difruscolo ; Luigi Maria SpecchioEffects of rivastigmine on motor and cognitive impairment in Huntington's disease.
001212 (2005) Anna K. Hödl ; Raphael M. BonelliHuntington's disease and minocycline.
001518 (2006) Richard Dubinsky [États-Unis] ; Carolyn GrayCYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease.
001811 (2006) Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan ; Robert A. Hauser ; Juan Sanchez-RamosOpen-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
001912 (2007) Christopher Kenney [États-Unis] ; Christine Hunter ; Anthony Davidson ; Joseph Jankovic [États-Unis]Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
001930 (2007) Norman ReynoldsRevisiting safety of minocycline as neuroprotection in Huntington's disease.
001D95 (2007) Penelope Hogarth [États-Unis] ; Luca Lovrecic ; Dimitri KraincSodium phenylbutyrate in Huntington's disease: a dose-finding study.
001E44 (2007) Carmine Vitale [Italie] ; Stefano Marconi ; Luigi Di Maio ; Giuseppe De Michele ; Katia Longo ; Vincenzo Bonavita ; Paolo BaroneShort-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
002219 (2008) Josef Priller ; Daniel Ecker ; Bernhard Landwehrmeyer ; David CraufurdA Europe-wide assessment of current medication choices in Huntington's disease.
002357 (2008) Zulema Salazar ; Lorena Tschopp ; Cristian Calandra ; Federico MicheliPisa syndrome and parkinsonism secondary to valproic acid in Huntington's disease.
002503 (2009) Livia Brusa [Italie] ; Antonio Orlacchio ; Vincenzo Moschella ; Cesare Iani ; Giorgio Bernardi ; Nicola Biagio MercuriTreatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
002856 (2009) Adrienne Curtis [Royaume-Uni] ; Ian Mitchell ; Smitaa Patel ; Natalie Ives ; Hugh RickardsA pilot study using nabilone for symptomatic treatment in Huntington's disease.
002B57 (2010) Gonzalo J. Revuelta ; Claudia Testa ; James G. GreeneWriter's cramp: a potential early feature of Huntington's disease.
002D47 (2010) Maximilian Gahr ; Michael Orth ; Birgit AblerNeuroleptic malignant syndrome with aripiprazole in Huntington's disease.
002D55 (2010) H Christopher Hyson ; Karl Kieburtz ; Ira Shoulson ; Michael Mcdermott ; Bernard Ravina ; Elisabeth A. De Blieck ; Merit E. Cudkowicz ; Robert J. Ferrante ; Peter Como ; Sam Frank ; Carol Zimmerman ; Merit E. Cudkowicz ; Kimberly Ferrante ; Kristyn Newhall ; Danna Jennings ; Tammie Kelsey ; Francis Walker ; Vicki Hunt ; Susan Daigneault ; Michele Goldstein ; Joseph Weber ; Arthur Watts ; M Flint Beal ; Susan E. Browne ; Linda J. MetakisSafety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Huntington Disease (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Huntington Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Huntington Disease (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024